Is intravenous injection of mesenchymal stem cells effective in treating liver fibrosis?
MSC administration is able to protect against liver fibrosis. Intravenous injection is the most favorable treatment modality through promotion of IL10 expression.
The implications for nursing involve increased recognition of the range of normal experiences and acknowledgment that pain is a primary basis for women coming to the hospital as opposed to cervical dilation. Reevaluating the instruction the healthcare providers give to women is warranted.